Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $3.39 USD
Change Today +0.10 / 3.04%
Volume 161.9K
ICAD On Other Exchanges
Symbol
Exchange
NASDAQ CM
Stuttgart
As of 8:10 PM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

98 Spit Brook Road

Suite 100

Nashua, NH 03062

United States

Phone: 603-882-5200

Fax: 603-880-3843

iCAD, Inc. provides advanced image analysis, workflow solutions, and radiation therapy for the early identification and treatment of cancer. Segments The company has two segments, Cancer Detection and Cancer Therapy. In the Cancer Detection segment, the company’s solutions include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, a range of upgradeable computer-aided detection (CAD) systems and workflow solutions for mammography, magnetic resonance imaging (MRI), and computed tomography (CT). The Cancer Therapy segment includes the Xoft Axxent Electronic Brachytherapy (eBx) system, an isotope-free cancer treatment platform technology. Radiation Therapy The Xoft eBx system utilizes a miniaturized high dose rate yet low energy X-ray source to apply radiation directly to the cancerous site. The Xoft eBx system delivers clinical dose rates similar to traditional radio-active systems. Customers of the Xoft eBx system include university research and community hospitals, private and governmental institutions, doctors’ offices, cancer care clinics, veterinary facilities, and strategic partnerships with radiation oncology service providers that enable the supervised delivery of the technology in dermatologist offices. The Xoft System is a viable alternative treatment option for patients with lesions in cosmetically challenging locations (ear, nose, scalp, neck), locations that experience difficulties in healing (lower legs, upper chest, fragile skin), patients on anticoagulants, and patients who are anxious about surgery. eBx Products eBx Treatment for Breast Cancer Axxent eBx The portable Axxent eBx system uses isotope-free miniaturized X-ray tube technology to deliver therapy directly to cancer sites with minimal radiation exposure to surrounding healthy tissue. The Axxent eBx system is FDA-cleared for the treatment of early stage breast cancer, endometrial cancer and skin cancer, as well as for the treatment of other cancers or conditions where radiation therapy is indicated, including Intraoperative Radiation Therapy (IORT). The company offers FDA-cleared applicators for the utilization of the Axxent eBx system, including breast applicators for IORT and APBI in the treatment of breast cancer, vaginal applicators for the treatment of endometrial cancer, cervical applicators for the treatment of cervical cancer, and skin applicators for the treatment of non-melanoma skin cancers. The single-use breast IORT and APBI applicators are offered in a variety of sizes based on clinical need. The company also provides the 50kV isotope-free energy source, a comprehensive service warranty program, and various accessories such as the Axxent eBx Rigid Shield for internal IORT shielding. The 50kV energy source is sold either as an annual contract customized to individual customer volume/usage requirements or on a single unit basis. In 2014, the company developed and launched a new Axxent SPX Controller, which includes an optimized skin treatment arm customized for compatibility in confined patient treatment rooms in physician office-based facilities. Customers of the Xoft eBx system include university research and community hospitals, private and governmental institutions, doctors’ offices, cancer care clinics, and veterinary facilities in the United States, Europe and Asia and strategic partnerships with radiation oncology service providers that enable the supervised delivery of the technology in dermatology offices. Cancer Detection Digital Mammography CAD products: Advanced Image Analysis and Workflow Solutions in Breast Imaging (Mammography) The company develops and markets a range of CAD solutions for digital and film-based mammography systems. iCAD’s SecondLook Digital CAD is based on patented algorithms that analyze the data, automatically identifying and marking suspicious regions in the images. The CAD provides the radiologist with a second look, which helps the radiologist detect actionable missed cancers earlier than screening mammography alone. SecondLook dete

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ICAD:US $3.39 USD +0.10

ICAD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Elekta AB kr57.85 SEK -0.35
Hologic Inc $38.03 USD +0.49
Merge Healthcare Inc $5.46 USD -0.03
View Industry Companies
 

Industry Analysis

ICAD

Industry Average

Valuation ICAD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.1x
Price/Book 0.8x
Price/Cash Flow 33.8x
TEV/Sales 0.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ICAD INC, please visit www.icadmed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.